Treatment dilemma in the care of older adults with advanced lung cancer

Ajeet Gajra, Ankit Anand, Kah Poh Loh, Supriya Mohile


There are persistent knowledge gaps in the management of older patients with advanced lung cancer. Despite significant advances in the treatment over the past decade, mortality from lung cancer continues to increase in patients over age 70 years (1). Thus, advances in the treatment of lung cancer have minimally impacted this large subgroup of population. While patients 70 years or older account for almost half the patients with lung cancer, they are typically under-represented on clinical trials (1).